| Date Filed | Type | Description |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/01/2023 |
8-K
| Quarterly results |
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/02/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 04/14/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/14/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/01/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/23/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 01/31/2023 |
SC 13G/A
| LeMaitre George W reports a 11.5% stake in LeMaitre Vascular, Inc. |
| 01/25/2023 |
5
| O'Connor John James (Director) has filed a Form 5 on LEMAITRE VASCULAR INC |
| 01/20/2023 |
SC 13G
| BlackRock Inc. reports a 14.9% stake in LEMAITRE VASCULAR INC |
| 01/18/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/13/2023 |
SC 13G
| Copeland Capital Management, LLC reports a 6.2% stake in LEMAITRE VASCULAR INC |
| 11/08/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/27/2022 |
8-K
| Quarterly results |
| 09/23/2022 |
8-K
| Appointed a new director |
| 08/05/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/28/2022 |
8-K
| Quarterly results |
| 06/03/2022 |
8-K
| Quarterly results |
| 05/31/2022 |
SD
| Form SD - Specialized disclosure report: |
| 05/10/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 02/28/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 02/24/2022 |
8-K
| Quarterly results |
| 02/14/2022 |
5
| O'Connor John James (Director) has filed a Form 5 on LEMAITRE VASCULAR INC |
| 02/11/2022 |
SC 13G/A
| LeMaitre George W reports a 11.7% stake in LeMaitre Vascular, Inc. |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 5.9% stake in LeMaitre Vascular Inc. |
|